Archive for August, 2009

Failing heart, failing kidney: Double trouble?

Concomitant kidney dysfunction and/or worsening renal function in patients with heart failure is a frequent finding and is associated with a poor prognosis. Current treatment of heart failure has beneficial effects on cardiac function but does not favorably affect renal function. The possibility to improve renal function and/or obtain kidney protection with new drugs or devices is still uncertain.

More: continued here

Monday, August 31st, 2009

Heart failure patients may benefit from treatment of anemia with erythropoietin

Heart failure patients may benefit from treatment of anemia similarly to those with chronic kidney disease or cancer.

More: continued here

Monday, August 31st, 2009

No evidence for the routine use of aspirin in people with asymptomatic vascul…

The routine use of aspirin for the primary prevention of vascular events in people with asymptomatic disease cannot be supported, according to results from the Aspirin for Asymptomatic Atherosclerosis study.

More: continued here

Monday, August 31st, 2009

Double doses of clopidogrel better than standard doses for heart patients und…

A landmark international study led by McMaster University researchers found high doses of the blood thinner clopidogrel significantly reduce complications in heart patients undergoing angioplasty to clear blocked arteries.

More: continued here

Monday, August 31st, 2009

New oral antiplatelet agent ticagrelor first to show reduction in cardiovascu…

The presentation of the PLATO study showed that ticagrelor reduced the rate of cardiovascular events from 11.7 percent to 9.8 percent compared clopidogrel, without an increase in major bleeding.

More: continued here

Monday, August 31st, 2009

Dabigatran vs. warfarin as long-term anticoagulant therapy in atrial fibrilla…

The anticoagulant dabigatran is more effective than warfarin in the prevention of stroke in patients with atrial fibrillation, according to results from the RE-LY study (Randomized Evaluation of Long-term anticoagulant therapY).

More: continued here

Monday, August 31st, 2009

Otamixaban for the treatment of patients with non-ST-elevation acute coronary…

Data from a Phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes.

More: continued here

Monday, August 31st, 2009

Opals set to shine with new grading technology

CSIRO and a consortium of Australian Opal miners have unveiled the world’s first automated device to grade opals using image analysis, at the 2009 National Council of Jewelery Valuers forum in Sydney.

More: continued here

Monday, August 31st, 2009

Termites eavesdrop on competitors to survive

The drywood termite, Cryptotermes secundus, eavesdrops on its more aggressive subterranean competitor, Coptotermes acinaciformis, to avoid contact with it, according to scientists from CSIRO Entomology and the University of New South Wales at the Australian Defence Force Academy.

More: continued here

Monday, August 31st, 2009

Carbon monoxide linked to heart problems in elderly

Exposure to carbon monoxide, even at levels well below national limits, is associated with an increased risk of hospitalization for the elderly with heart problems, according to a study published today in Circulation: Journal of the American Heart Association.

More: continued here

Monday, August 31st, 2009